DSM is to close down production of bulk vitamin C in the US and cut
costs at its plant in Dalry, Scotland, as part of a series of
measures to ease pressure on its vitamin business, reports
Dominique Patton.
DSM has reached an agreement with China's leading pharmaceuticals
group to buy out its stake in a vitamins joint venture,
strengthening the Dutch group's presence on the Chinese market,
reports Dominique Patton.
Tea polyphenols are more bioavailable when delivered as
encapsulated green tea extract than when taken as a traditional
beverage, according to a small trial.
Dutch ingredients company DSM revealed yesterday that its muscle
recovery ingredient PeptoPro will be marketed in a new range of
products worldwide by Europe's biggest sports nutrition company
Haleko.
An energy drink developed by chemicals firm DSM is set to gain
further exposure prior to a commercial launch with use by the Dutch
national football team during Euro 2004.
DSM Food Specialties has launched a new gelatin-free version of its
CaroCare beta-carotene supplement - a move prompted by increasing
consumer concern about beef-derived products following the BSE
scare.
Dutch vitamins and ingredients company DSM says its new sports
drink, PeptoProSports, has cleared tests for banned substances,
ahead of its launch during this year's Olympics.
Dutch chemicals company DSM is cutting a further 500 jobs in
support services and manufacturing staff departments to improve
performance at its Geleen production site, it said today.
DSM Food Specialties is hoping to test its new recovery drink on a
team of racing drivers next summer. The trial could lead to a more
long-term involvement with the sport and raise awareness of the
finished product, said the Dutch...
Dutch fine chemcials group DSM is to market creatine directly to
the consumer through Swiss partner Dolder, in a bid to retain its
share of the German sports nutrition market.
Following the completion yesterday of its acquisition of the Roche
Vitamins business, DSM says it has already identified over €150
million improvement potential in the acquisition, in addition to
more than €75 million in savings expected...
Netherlands-based DSM and Swiss chemicals group Roche said today
they have received approval from the US Federal Trade Commission
for the Roche vitamins deal. With final transfer of the business to
DSM expected at the end of the month,...
Life science company DSM is in top gear this year, with the
European Patent Office revealing that the company filed the largest
number of biotechnology patent applications in Europe this year,
for the second year in succession.
With sales and operating profit both diving in the second quarter
the summer sun is not shining on DSM with the outlook also
decidedly gloomy for the next three months. However all is not
bleak with a rebound predicted by the year...
The European Commission has conditionally cleared DSM's acquisition
of Roche Vitamins and Fine Chemicals, it said yesterday. The deal,
likely to be completed in the third quarter 2003, will cost DSM
€1,750 million.
DSM will wipe €200 million off the purchase price for Roche's
vitamins unit, owing to the unit's recent poor performance and
costs associated with the long approval process of competition
authorities, said the company today.
The global economic downturn marked 2003 first quarter results for
Dutch life science company DSM, but strong autonomous volume growth
boosted figures to higher than 2002.
DSM Food Specialties will be presenting its second generation Lafti
probiotic strains, formulated for use in dietary supplements, at
the forthcoming Vitafoods show in Geneva.
The Dutch life science company this week presented its sustainable
strategy, emphasising the company's progress in the fields of
'People, Planet and Profit'.
Dutch speciality chemicals company DSM continues on its steady path
to growth with the announcement today that operating profit for
2002 reached €383 million, a 14 per cent rise on 2001, thanks in
part to 6 per cent autonomous volume...
Dutch life science company DSM, together with Agennix, a US
developer of recombinant human lactoferrin, has opened a new
manufacturing facility on DSM's fermentation site in Capua, Italy.
Dutch life science company DSM this week posted a net profit of
€959 million. DSM Food Specialties and DSM Bakery Ingredients
posted improved operating profits on the same period last year.